Evrofarma SA

Athens Stock Exchange EVROF.AT

Evrofarma SA Current Liabilities for the year ending December 31, 2023: USD 14.39 M

Evrofarma SA Current Liabilities is USD 14.39 M for the year ending December 31, 2023, a 6.16% change year over year. Current liabilities are obligations that are expected to be settled within one year, including accounts payable, short-term debt, and other current liabilities.

Evrofarma SA Current Liabilities for the year ending December 31, 2022 was USD 13.56 M, a 16.79% change year over year.
Evrofarma SA Current Liabilities for the year ending December 31, 2021 was USD 11.61 M, a -11.29% change year over year.
Evrofarma SA Current Liabilities for the year ending December 31, 2020 was USD 13.09 M, a -47.59% change year over year.
Evrofarma SA Current Liabilities for the year ending December 31, 2019 was USD 24.97 M, a 38.25% change year over year.

Key data

Date	Current Liabilities	Total Non-Current Liabilities	Shareholders' Equity	Long-Term Debt

Athens Stock Exchange: EVROF.AT

Evrofarma SA

CEO	Mr. Paschalis H. Papazilakis
IPO Date	June 13, 2000
Location	Greece
Headquarters	1st km Didymoteicho – Orestiada
Employees	166
Sector	Consumers Staples
Industries Dairy & Milk

Description

Evrofarma SA produces and sells dairy products in Greece. It offers milk, yoghurt, cheese, and fermented beverages. The company also exports its products. Evrofarma SA was founded in 1991 and is headquartered in Didymoteicho, Greece.

Key trends

Past 5 years